Skip to content

Drug interactions

Carbidopa-levodopa + Dihydroergotamine intranasal

Severity: Minor

Carbidopa-levodopa and Dihydroergotamine intranasal: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dihydroergotamine is a vasoconstrictor with serotonergic and dopaminergic activity. With levodopa, additive effects on blood pressure, nausea and dopaminergic effects are possible, but a clinically significant interaction is not well documented.

What this interaction means in plain words

Carbidopa-levodopa and Dihydroergotamine intranasal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Overlapping dopaminergic and serotonergic receptor activity; no well-established mechanism for harm.

What to do

Monitor for nausea, blood pressure changes and worsening of parkinsonian symptoms or dyskinesia. No routine dose change is needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Carbidopa-levodopa and Dihydroergotamine intranasal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Carbidopa-levodopa with Dihydroergotamine intranasal?

MediHelp rates the interaction as minor. Carbidopa-levodopa and Dihydroergotamine intranasal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Dihydroergotamine is a vasoconstrictor with serotonergic and dopaminergic activity. With levodopa, additive effects on blood pressure, nausea and dopaminergic effects are possible, but a clinically significant interaction is not well documented.

How serious is the interaction between Carbidopa-levodopa and Dihydroergotamine intranasal?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for nausea, blood pressure changes and worsening of parkinsonian symptoms or dyskinesia. No routine dose change is needed.

What other medicines interact with Carbidopa-levodopa?

MediHelp also lists interactions of Carbidopa-levodopa with, for example, Isocarboxazid, Phenelzine, Selegiline transdermal. The full list is on the Carbidopa-levodopa page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in